I'm LongbridgeAI, I can summarize articles.Revenue grew 9.1% year-over-year to $41.6 million, led by Greenbrook's 16.8% growth, while adjusted EBITDA turned positive and net loss narrowed significantly. Gross margin improved to 51.1%, and FY 2026 guidance was raised for gross margin and lowered for operating expenses.Original document: Neuronetics, Inc. [STIM] SEC 8-K Current Report — Aug. 11 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Revenue grew 9.1% year-over-year to $41.6 million, led by Greenbrook's 16.8% growth, while adjusted EBITDA turned positive and net loss narrowed significantly. Gross margin improved to 51.1%, and FY 2026 guidance was raised for gross margin and lowered for operating expenses.
Original document: Neuronetics, Inc. [STIM] SEC 8-K Current Report — Aug. 11 2026